Skip to main content
Clinical Trials/NCT05199779
NCT05199779
Completed
N/A

A Single Session Intervention Leveraging an Ultra-Brief Exercise for Building Self-Compassion Habits-A Randomized Controlled Trial

University of California, Berkeley1 site in 1 country135 target enrollmentFebruary 13, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Transdiagnostic Psychopathology
Sponsor
University of California, Berkeley
Enrollment
135
Locations
1
Primary Endpoint
Positive and Negative Affect Schedule (PANAS)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The study will test a single session self-compassion intervention that leverages an ultra-brief contemplative exercise. It will evaluate the effect of this intervention on psychopathology, stress, growth mindset, positive affect, self-compassion and the automaticity of self-compassion, as well as the relationships between these constructs and the automaticity of self-compassion. The participants will be undergraduate students at a large public university.

Detailed Description

The broad aims of the proposed research is to examine the outcomes of a single session psychological intervention and to further understand processes and factors associated with habit formation. undergraduate students at a large university will be randomly assigned to a self-compassion intervention (SCI), or an active control (AC), and complete assessments at baseline (pre-treatment) and 4 weeks later (post-treatment). The investigators seek to examine the following: (A1) Determine whether the group who receives the SCI, relative to the AC, will experience increased self-compassion, growth mindset and positive affect, as well as reduced stress and psychopathology. (A2) Evaluate whether the SCI group shows greater increases in automaticity of self-compassion compared to the AC pre- to post-treatment. (A3) Assess whether greater pre- to post-treatment increases in automaticity of self-compassionate are associated with increased self-compassion, growth mindset, and positive affect, as well as reductions in stress and psychopathology. The investigators hypothesize the following: (H1) SCI will promote greater increases in self-compassion, growth mindset, and positive affect, as well as greater reductions in stress and psychopathology from pre- to post-treatment, relative to AC. (H2) The SCI group will show greater increases in the automaticity of self-compassion than AC from pre- to post-treatment. (H3) Greater increases in the automaticity of self-compassion from pre- to post-treatment will be predicted by greater increases in self-compassion, growth mindset, and positive affect, as well as greater decreases in psychopathology and stress, from pre- to post treatment. To further understand the results obtained, the investigators will evaluate participants' frequency, adherence, and impressions of using the intervention.

Registry
clinicaltrials.gov
Start Date
February 13, 2022
End Date
April 29, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Allison Harvey

Professor of Clinical Psychology

University of California, Berkeley

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older.
  • English language proficiency.
  • Able and willing to give informed consent.

Exclusion Criteria

  • Does not have email address or access to email.
  • Not able/willing to participate in and/or complete the pre-treatment assessments

Outcomes

Primary Outcomes

Positive and Negative Affect Schedule (PANAS)

Time Frame: Change from baseline to post-treatment (week 4)

10 items with a 6 point response scale. Positive affect sub-scale only. Scoring: Positive Affect Score: Sum score of 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19. Scores range from 10 - 50. Higher scores = higher levels of positive affect. Negative Affect Score: Sum score of 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20. Scores range from 10 - 50. Lower scores = lower levels of negative affect.

DSM-5 Cross-Cutting Measure (DSM-XC)

Time Frame: Change from baseline to post-treatment (week 4)

22 items (suicidality item Q11 removed). 5-point scale (0=none or not at all; 1=slight or rare, less than a day or two; 2=mild or several days; 3=moderate or more than half the days; and 4=severe or nearly every day).

Kind of Person' Implicit Theory Scale (KOPITS)

Time Frame: Change from baseline to post-treatment (week 4)

8 items. 6-point response scale (1 = strongly agree; 6 = strongly disagree) Higher scores indicate a more growth mindset. Lower scores indicate a more fixed mindset. Score is sum of all items, with Q3, Q5, Q7, and Q8 reverse-scored. The formula for reverse-scoring an item is: ((Number of scale points) + 1) - (Respondent's answer)

Self-Report Behavioral Automaticity Index for Self-Compassion

Time Frame: Change from baseline to post-treatment (week 4)

20 items. 1-9 scale.

Sussex-Oxford Compassion for the Self Scale (SOCS-S)

Time Frame: Change from baseline to post-treatment (week 4)

Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self). Sub-scale items included.

10-item Perceived-Stress Scale (PSS-10)

Time Frame: Change from baseline to post-treatment (week 4)

10 items, 5 point response scale (from 0 = Never to 4 = Very Often) Scoring: Reverse score (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) items 4, 5, 7, \& 8 and then summing across all scale items.

Secondary Outcomes

  • Self-Report Behavioral Automaticity Index for Exercise(Change from baseline to post-treatment (week 4))
  • State Self-Compassion Scale Long Form (SSCS-L)(Change from pre-induction to post-induction at baseline and at post-treatment (week 4). Change in pre to post-induction changes in state self-compassion from baseline to post-treatment (week 4))
  • Real Self Overlap Scale(Change from baseline to post-treatment (week 4))

Study Sites (1)

Loading locations...

Similar Trials